A phase 3 study demonstrated that ritlecitinib was effective and well tolerated in patients with alopecia areata and ≥ 25% ...

Panelists discuss how the data from the BRAVE-AA1 and BRAVE-AA2 phase 3 trials demonstrated the safety and efficacy of baricitinib, leading to its FDA approval in 2022 as the first systemic treatment ...

The risk for alopecia areata is increased among patients with lower serum levels of vitamin D and zinc, but no relationship was observed with copper.

According to a recent study, comorbid chronic inflammatory diseases influence the prognosis of alopecia areata.

Neehar Sachdeva is a popular Instagram influencer who recently got married and is trending as she is suffering from Alopecia.

This study will evaluate HCW9302 in patients with moderate to severe alopecia areata. MIRAMAR, Fla., Feb. 03, 2025 (GLOBE ...

HCW Biologics gets US FDA nod to begin first-in-human phase 1 trial of HCW9302 to treat patients with moderate-to-severe alopecia areata: Miramar, Florida Wednesday, February 5, 2 ...

HCW Biologics Inc. (HCWB) a clinical-stage biopharmaceutical company, Monday said that the Food and Drug Administration (FDA)has ...

HCW Biologics shares are trading higher on Monday after the company announced clearance from the Food and Drug Administration ...

Alys Pharmaceuticals, Inc. (“Alys”), an immune-dermatology focused company, today announces that the U.S. Food and Drug Administration (FDA) and Health Canada have cleared the Investigational New Drug ...

A holistic or integrative approach to hair loss considers the hair growth cycle and hair loss from a nutritional, ...

Neehar Sachdeva, a US-based social media influencer, who suffers from alopecia areata, broke the internet by ditching wigs for her wedding day.